Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine 3-year follow-up for high-risk surgical patients
NCT03868709Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of penehyclidine in postoperative pulmonary complications (PPC), sponsored by Peking University First Hospital. Started Mar 2019; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT03868709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03868709.